Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Seminars in Immunology|May 11, 2019
Helper-like innate lymphoid cells and cancer immunotherapyAdeline Crinier, Eric Vivier, Mathieu BléryFrontiers in Immunology|June 26, 2020
MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICAYounghoon Kim, Christina Born, Mathieu Bléry, et al.The Journal of Experimental Medicine|June 28, 2006
Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-kappa B in B cell clonal anergyMathieu Bléry, Lina Tze, Lisa A Miosge, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
NK cells in central nervous system disordersAurélie Poli, Justyna Kmiecik, Olivia Domingues, et al.Journal of Biomedicine & Biotechnology|June 2, 2011
The role of natural killer cells in sepsisLaurent Chiche, Jean-Marie Forel, Guillemette Thomas, et al.Proceedings of the National Academy of Sciences of the United States of America|June 30, 2009
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivoCaroline Sola, Pascale André, Céline Lemmers, et al.Haematologica|January 2, 2016
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cellsLoredana Ruggeri, Elena Urbani, Pascale André, et al.Cancer Research|November 2, 2014
IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphomaAnne Marie-Cardine, Nicolas Viaud, Nicolas Thonnart, et al.Elife|September 7, 2017
High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptorsAntoine Marçais, Marie Marotel, Sophie Degouve, et al.Blood|December 12, 2013
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodiesHolbrook E Kohrt, Ariane Thielens, Aurelien Marabelle, et al.Pageof 2